MD1003-AMN MD1003 in Adrenomyeloneuropathy

Clinical trial NCT02961803 · COMPLETED

Trial details

NCT number: NCT02961803
Sponsor: MedDay Pharmaceuticals SA
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Adrenomyeloneuropathy Adrenoleukodystrophy AMN

Start date: 2014-10-01
Primary completion: 2016-06-01
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.